CDK1 and acute myeloid leukemia: Some studies suggested that single genes, selected for investigation based on prescreening data from independent experimental systems, e.g., TGM2, CDK1, miR-331-5p, and miR-27a, were significantly deregulated between diagnosis and relapse of AML [106–108].